A carregar...

Posaconazole Therapeutic Drug Monitoring in Pediatrics and Young Adults with Cancer

BACKGROUND: Limited information exists regarding the use of posaconazole for treating systemic fungal infections in children, adolescent, and young adult patients with cancer. At St. Jude Children’s Research Hospital, the recommended posaconazole dose in patients less than 34 kg is 18–24 mg/kg daily...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Pharmacother
Main Authors: Bernardo, Valeria A., Cross, Shane J., Crews, Kristine R., Flynn, Patricia M., Hoffman, James M., Knapp, Katherine M., Pauley, Jennifer L., Molinelli, Alejandro R., Greene, William L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384822/
https://ncbi.nlm.nih.gov/pubmed/23737511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1345/aph.1R775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!